Literature DB >> 29948610

Working With Persons Who Inject Drugs and Live in Rural Areas: Implications From China/Vietnam for the USA.

Don C Des Jarlais1, Theodore M Hammett2,3, Binh Kieu4, Yi Chen5, Jonathan Feelemyer6.   

Abstract

PURPOSE OF REVIEW: To describe a small city/rural area HIV prevention project (the Cross Border Project) implemented in Ning Ming County, Guangxi Province, China, and Lang Son province, Vietnam, and consider its implications for addressing the opioid/heroin epidemic in small cities/rural areas in the USA. The description and the outcomes of the Cross Border project were taken from published reports, project records, and recent data provided by local public health authorities. Evaluation included serial cross-sectional surveys of people who inject drugs to assess trends in risk behaviors and HIV prevalence. HIV incidence was estimated from prevalence among new injectors and through BED testing. RECENT
FINDINGS: The Cross Border project operated from 2002 to 2010. Key components of the project 2 included the use of peer outreach workers for HIV/AIDS education, distribution of sterile injection equipment and condoms, and collection of used injection equipment. The project had the strong support of local authorities, including law enforcement, and the general community. Significant reductions in risk behavior, HIV prevalence, and estimated HIV incidence were observed. Community support for the project was maintained. Activities have been continued and expanded since the project formally ended. The Cross Border project faced challenges similar to those occurring in the current opioid crisis in US small cities/rural areas: poor transportation, limited resources (particularly trained staff), poverty, and potential community opposition to helping people who use drugs. It should be possible to adapt the strategies used in the Cross Border project to small cities/rural areas in the US opioid epidemic.

Entities:  

Keywords:  China; Cross border; HIV; Persons who inject drugs; Vietnam

Mesh:

Year:  2018        PMID: 29948610      PMCID: PMC6873704          DOI: 10.1007/s11904-018-0405-0

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  10 in total

1.  Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia.

Authors:  C Beyrer; M H Razak; K Lisam; J Chen; W Lui; X F Yu
Journal:  AIDS       Date:  2000-01-07       Impact factor: 4.177

2.  Community attitudes toward HIV prevention for injection drug users: findings from a cross-border project in southern China and northern Vietnam.

Authors:  Theodore M Hammett; Giulia D Norton; Ryan Kling; Wei Liu; Yi Chen; Doan Ngu; Kieu Thanh Binh; Ha Viet Dong; Don C Des Jarlais
Journal:  J Urban Health       Date:  2005-09       Impact factor: 3.671

3.  Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project.

Authors:  Don C Des Jarlais; Ryan Kling; Theodore M Hammett; Doan Ngu; Wei Liu; Yi Chen; Kieu Thanh Binh; Patricia Friedmann
Journal:  AIDS       Date:  2007-12       Impact factor: 4.177

4.  Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.

Authors:  Neha S Shah; Yen T Duong; Linh-Vi Le; Nguyen Anh Tuan; Bharat S Parekh; Hoang Thi Thanh Ha; Quang Duy Pham; Cao Thi Thu Cuc; Trudy Dobbs; Tran Hong Tram; Truong Thi Xuan Lien; Nick Wagar; Chunfu Yang; Amy Martin; Mitchell Wolfe; Nguyen Tran Hien; Andrea A Kim
Journal:  AIDS Res Hum Retroviruses       Date:  2017-03-13       Impact factor: 2.205

5.  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

Authors:  Don C Des Jarlais; Ann Nugent; Alisa Solberg; Jonathan Feelemyer; Jonathan Mermin; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-12-11       Impact factor: 17.586

Review 6.  Relationship between Nonmedical Prescription-Opioid Use and Heroin Use.

Authors:  Wilson M Compton; Christopher M Jones; Grant T Baldwin
Journal:  N Engl J Med       Date:  2016-01-14       Impact factor: 91.245

7.  Reconstruction of subregional diffusion of HIV infection among injecting drug users in Southeast Asia: implications for early intervention.

Authors:  G V Stimson
Journal:  AIDS       Date:  1994-11       Impact factor: 4.177

8.  HIV Infection Linked to Injection Use of Oxymorphone in Indiana, 2014-2015.

Authors:  Philip J Peters; Pamela Pontones; Karen W Hoover; Monita R Patel; Romeo R Galang; Jessica Shields; Sara J Blosser; Michael W Spiller; Brittany Combs; William M Switzer; Caitlin Conrad; Jessica Gentry; Yury Khudyakov; Dorothy Waterhouse; S Michele Owen; Erika Chapman; Jeremy C Roseberry; Veronica McCants; Paul J Weidle; Dita Broz; Taraz Samandari; Jonathan Mermin; Jennifer Walthall; John T Brooks; Joan M Duwve
Journal:  N Engl J Med       Date:  2016-07-21       Impact factor: 91.245

9.  Patterns of HIV prevalence among injecting drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China.

Authors:  Don C Des Jarlais; Patrick Johnston; Patricia Friedmann; Ryan Kling; Wei Liu; Doan Ngu; Yi Chen; Tran V Hoang; Meng Donghua; Ly K Van; Nguyen D Tung; Kieu T Binh; Theodore M Hammett
Journal:  BMC Public Health       Date:  2005-08-24       Impact factor: 3.295

10.  Controlling HIV epidemics among injection drug users: eight years of Cross-Border HIV prevention interventions in Vietnam and China.

Authors:  Theodore M Hammett; Don C Des Jarlais; Ryan Kling; Binh Thanh Kieu; Janet M McNicholl; Punneeporn Wasinrapee; J Stephen McDougal; Wei Liu; Yi Chen; Donghua Meng; Ngu Doan; Huu Nguyen Tho; Ngoc Hoang Quyen; Van Hoang Tren
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

  10 in total
  1 in total

1.  Healthcare stigma and HIV risk among rural people who inject drugs.

Authors:  Hilary L Surratt; Janet K Otachi; Christopher J McLouth; Nikita Vundi
Journal:  Drug Alcohol Depend       Date:  2021-06-25       Impact factor: 4.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.